


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.49%
+2.30%
+21.70%
-8.63%
-5.65%
BSX
Boston Scientific
$75.75
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Risk Analysis

Investors losing their confidence
BSX Price Performance
$93.53 (-19.01%)
$99.02 (-23.50%)
$97.32 (-22.16%)
$97.16 (-22.04%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
BSX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BSX Street Sentiment is bullish and have positive views on the near-term outlook
BSX has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 07, 2026
Reiterate
Buy
Truist
Dec 18, 2025
Reiterate
Buy
Canaccord Genuity
Dec 17, 2025
Reiterate
Outperform
RBC
Nov 21, 2025
Reiterate
Buy
BTIG
Nov 21, 2025
Upgrade
Buy
Zacks
SYK
Stryker
386.06
+0.53%
BDX
Becton, Dickinson and
176.66
-2.38%
TFX
Teleflex Incorporate
119.02
+6.37%
RMD
ResMed
257.06
+1.78%
PROF
Profound Medical Cor
7.78
+5.07%
What is BSX current stock price?
What are BSX stock strengths?
What is BSX Risk Level?
What is BSX market cap and volume?
What is BSX current Stock IQ?
Should I buy BSX stock right now?
Is BSX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BSX?
What does a 'Strong Sell' rating mean for BSX?
What factors influence BSX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
BSX
Boston Scientific
Current Price
$75.75
Runners Also Watch
SYK
Stryker
386.06
+0.53%
BDX
Becton, Dickinson and
176.66
-2.38%
TFX
Teleflex Incorporate
119.02
+6.37%
RMD
ResMed
257.06
+1.78%
PROF
Profound Medical Cor
7.78
+5.07%

BSX Price Performance
$93.53 (-19.01%)
$99.02 (-23.50%)
$97.32 (-22.16%)
$97.16 (-22.04%)
BSX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
BSX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BSX Street Sentiment is bullish and have positive views on the near-term outlook
BSX has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
BSX Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Risk Analysis

Investors losing their confidence
BSX Latest Analysis
Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths. Boston Scientific Corp (NYSE:BSX) on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems from clinical settings following reports of deployment complications that have been linked to serious injuries and deaths.Stent UseThe AXIOS Electrocautery-Enhanced Stent and Delivery System is designed to enable endoscopic drainage of pancreatic pseudocysts or walled-off necros
Thu Feb 26, 2026
Here is Why Boston Scientific Corporation (BSX) is Highly Favored by Hedge Funds. Boston Scientific Corporation (NYSE:BSX) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 17 the price target on Boston Scientific Corporation (NYSE:BSX) was reduced from $112 to $109 by Canaccord Genuity analyst William Plovanic. The analyst reiterated his Buy rating on the stock which still yields a [….]
Mon Feb 23, 2026
BSX Posts Q4 Earnings: Should You Buy Sell or Hold the Stock?. Boston Scientific tops Q4 estimates but shares sink on supply woes and EP losses. Can strong growth drivers fuel a 2026 rebound?
Fri Feb 13, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.